Oliver Luxxe Assets’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
Oliver Luxxe Assets's CPRX Position: Q3 2026 in Review
Oliver Luxxe Assets sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 49,744 shares — an estimated $1.56M sold.
Oliver Luxxe Assets first reported a position in CPRX in Q3 2024 and held it in 8 quarters. The position peaked at $2.39M in Q1 2026. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- Oliver Luxxe Assets reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Oliver Luxxe Assets sold 49,744 Catalyst Pharmaceutical shares in Q3 2026, an estimated $1.56M.
- Oliver Luxxe Assets first reported a position in Catalyst Pharmaceutical in Q3 2024 and held it in 8 quarters.
- Oliver Luxxe Assets's Catalyst Pharmaceutical position peaked at $2.39M in Q1 2026.
- 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on Oliver Luxxe Assets's 13F filing for Q3 2026, filed 14 Oct 2026.